PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis

The transcription factor STAT5 (signal transducer and activator of transcription 5) is frequently activated in hematological malignancies and represents an essential signaling node downstream of the BCR-ABL oncogene. STAT5 can be phosphorylated at three positions, on a tyrosine and on the two serine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Berger, Angelika (VerfasserIn) , Hoelbl-Kovacic, A. (VerfasserIn) , Bourgeais, J. (VerfasserIn) , Hoefling, L. (VerfasserIn) , Warsch, W. (VerfasserIn) , Grundschober, E. (VerfasserIn) , Uras, I. Z. (VerfasserIn) , Menzl, I. (VerfasserIn) , Putz, E. M. (VerfasserIn) , Hoermann, G. (VerfasserIn) , Schuster, Christoph M. (VerfasserIn) , Fajmann, S. (VerfasserIn) , Leitner, E. (VerfasserIn) , Kubicek, S. (VerfasserIn) , Moriggl, R. (VerfasserIn) , Gouilleux, F. (VerfasserIn) , Sexl, V. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: Leukemia
Year: 2013, Jahrgang: 28, Heft: 3, Pages: 629-641
ISSN:1476-5551
DOI:10.1038/leu.2013.351
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/leu.2013.351
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/leu2013351
Volltext
Verfasserangaben:A. Berger, A. Hoelbl-Kovacic, J. Bourgeais, L. Hoefling, W. Warsch, E. Grundschober, I.Z. Uras, I. Menzl, E.M. Putz, G. Hoermann, C. Schuster, S. Fajmann, E. Leitner, S. Kubicek, R. Moriggl, F. Gouilleux and V. Sexl

MARC

LEADER 00000caa a2200000 c 4500
001 1740383583
003 DE-627
005 20220819031850.0
007 cr uuu---uuuuu
008 201123r20142013xx |||||o 00| ||eng c
024 7 |a 10.1038/leu.2013.351  |2 doi 
035 |a (DE-627)1740383583 
035 |a (DE-599)KXP1740383583 
035 |a (OCoLC)1341377961 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Berger, Angelika  |e VerfasserIn  |0 (DE-588)1064171311  |0 (DE-627)813064759  |0 (DE-576)423713183  |4 aut 
245 1 0 |a PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis  |c A. Berger, A. Hoelbl-Kovacic, J. Bourgeais, L. Hoefling, W. Warsch, E. Grundschober, I.Z. Uras, I. Menzl, E.M. Putz, G. Hoermann, C. Schuster, S. Fajmann, E. Leitner, S. Kubicek, R. Moriggl, F. Gouilleux and V. Sexl 
264 1 |c 2014 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a advance online publication,13 December 2013 
500 |a Gesehen am 23.11.2020 
520 |a The transcription factor STAT5 (signal transducer and activator of transcription 5) is frequently activated in hematological malignancies and represents an essential signaling node downstream of the BCR-ABL oncogene. STAT5 can be phosphorylated at three positions, on a tyrosine and on the two serines S725 and S779. We have investigated the importance of STAT5 serine phosphorylation for BCR-ABL-induced leukemogenesis. In cultured bone marrow cells, expression of a STAT5 mutant lacking the S725 and S779 phosphorylation sites (STAT5SASA) prohibits transformation and induces apoptosis. Accordingly, STAT5SASA BCR-ABL+ cells display a strongly reduced leukemic potential in vivo, predominantly caused by loss of S779 phosphorylation that prevents the nuclear translocation of STAT5. Three distinct lines of evidence indicate that S779 is phosphorylated by group I p21-activated kinase (PAK). We show further that PAK-dependent serine phosphorylation of STAT5 is unaffected by BCR-ABL tyrosine kinase inhibitor treatment. Interfering with STAT5 phosphorylation could thus be a novel therapeutic approach to target BCR-ABL-induced malignancies. 
534 |c 2013 
700 1 |a Hoelbl-Kovacic, A.  |e VerfasserIn  |4 aut 
700 1 |a Bourgeais, J.  |e VerfasserIn  |4 aut 
700 1 |a Hoefling, L.  |e VerfasserIn  |4 aut 
700 1 |a Warsch, W.  |e VerfasserIn  |4 aut 
700 1 |a Grundschober, E.  |e VerfasserIn  |4 aut 
700 1 |a Uras, I. Z.  |e VerfasserIn  |4 aut 
700 1 |a Menzl, I.  |e VerfasserIn  |4 aut 
700 1 |a Putz, E. M.  |e VerfasserIn  |4 aut 
700 1 |a Hoermann, G.  |e VerfasserIn  |4 aut 
700 1 |a Schuster, Christoph M.  |e VerfasserIn  |0 (DE-588)1037336062  |0 (DE-627)755492218  |0 (DE-576)169902153  |4 aut 
700 1 |a Fajmann, S.  |e VerfasserIn  |4 aut 
700 1 |a Leitner, E.  |e VerfasserIn  |4 aut 
700 1 |a Kubicek, S.  |e VerfasserIn  |4 aut 
700 1 |a Moriggl, R.  |e VerfasserIn  |4 aut 
700 1 |a Gouilleux, F.  |e VerfasserIn  |4 aut 
700 1 |a Sexl, V.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 28(2014), 3, Seite 629-641  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis 
773 1 8 |g volume:28  |g year:2014  |g number:3  |g pages:629-641  |g extent:13  |a PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis 
856 4 0 |u https://doi.org/10.1038/leu.2013.351  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/leu2013351  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201123 
993 |a Article 
994 |a 2014 
998 |g 1037336062  |a Schuster, Christoph M.  |m 1037336062:Schuster, Christoph M.  |d 700000  |d 712000  |d 712100  |e 700000PS1037336062  |e 712000PS1037336062  |e 712100PS1037336062  |k 0/700000/  |k 1/700000/712000/  |k 2/700000/712000/712100/  |p 11 
999 |a KXP-PPN1740383583  |e 3810436267 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["advance online publication,13 December 2013","Gesehen am 23.11.2020"],"language":["eng"],"recId":"1740383583","person":[{"display":"Berger, Angelika","roleDisplay":"VerfasserIn","role":"aut","family":"Berger","given":"Angelika"},{"role":"aut","display":"Hoelbl-Kovacic, A.","roleDisplay":"VerfasserIn","given":"A.","family":"Hoelbl-Kovacic"},{"family":"Bourgeais","given":"J.","roleDisplay":"VerfasserIn","display":"Bourgeais, J.","role":"aut"},{"display":"Hoefling, L.","roleDisplay":"VerfasserIn","role":"aut","family":"Hoefling","given":"L."},{"family":"Warsch","given":"W.","display":"Warsch, W.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"E.","family":"Grundschober","role":"aut","roleDisplay":"VerfasserIn","display":"Grundschober, E."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Uras, I. Z.","given":"I. Z.","family":"Uras"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Menzl, I.","given":"I.","family":"Menzl"},{"role":"aut","display":"Putz, E. M.","roleDisplay":"VerfasserIn","given":"E. M.","family":"Putz"},{"given":"G.","family":"Hoermann","role":"aut","display":"Hoermann, G.","roleDisplay":"VerfasserIn"},{"display":"Schuster, Christoph M.","roleDisplay":"VerfasserIn","role":"aut","family":"Schuster","given":"Christoph M."},{"family":"Fajmann","given":"S.","roleDisplay":"VerfasserIn","display":"Fajmann, S.","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Leitner, E.","role":"aut","family":"Leitner","given":"E."},{"given":"S.","family":"Kubicek","role":"aut","display":"Kubicek, S.","roleDisplay":"VerfasserIn"},{"given":"R.","family":"Moriggl","role":"aut","display":"Moriggl, R.","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Gouilleux, F.","given":"F.","family":"Gouilleux"},{"display":"Sexl, V.","roleDisplay":"VerfasserIn","role":"aut","family":"Sexl","given":"V."}],"title":[{"title_sort":"PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis","title":"PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis"}],"physDesc":[{"extent":"13 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"origin":[{"dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"recId":"32046699X","language":["eng"],"note":["Gesehen am 15.03.04"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesisLeukemia","part":{"extent":"13","text":"28(2014), 3, Seite 629-641","volume":"28","pages":"629-641","issue":"3","year":"2014"},"pubHistory":["Nachgewiesen 11.1997 -"],"title":[{"title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia"}]}],"name":{"displayForm":["A. Berger, A. Hoelbl-Kovacic, J. Bourgeais, L. Hoefling, W. Warsch, E. Grundschober, I.Z. Uras, I. Menzl, E.M. Putz, G. Hoermann, C. Schuster, S. Fajmann, E. Leitner, S. Kubicek, R. Moriggl, F. Gouilleux and V. Sexl"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"id":{"doi":["10.1038/leu.2013.351"],"eki":["1740383583"]}} 
SRT |a BERGERANGEPAKDEPENDE2014